CN1197643A - Wound ointment - Google Patents
Wound ointment Download PDFInfo
- Publication number
- CN1197643A CN1197643A CN 97103257 CN97103257A CN1197643A CN 1197643 A CN1197643 A CN 1197643A CN 97103257 CN97103257 CN 97103257 CN 97103257 A CN97103257 A CN 97103257A CN 1197643 A CN1197643 A CN 1197643A
- Authority
- CN
- China
- Prior art keywords
- cod
- wound
- liver oil
- medicine
- hibitane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The wound ointment of the present invention is non-polar menstruum capable of promote healing of wound including postoperative incision, and it contains chlorhexidine acetate in 0.1-5% and cod-liver oil or its product in 95-99.5%. Wound ointment after disinfection may be dressed directly, or may be painted onto gauze, which is applied after being high pressure disinfected.
Description
The present invention relates to multiple surgical wound of a kind of treatment and scalpel edge, promote the nonpolar solvent medicine that wound is fullyed recover from an illness and closed.
Present this type of medicine of clinical use mainly contains Vickers ointment, the husky bar of vaseline and celebrating Da Sha bar.But the preparation of Vickers ointment is loaded down with trivial details, the cost height, and owing to contain iodoform, life-time service can cause dyschromasia, influences clinical observation and treatment, and the husky bar raw material of vaseline viscosity is big, preparation is difficult for, and very easily pollutes, and easily human body is produced stimulation, cause exclusion reaction, influence the absorption of human body medicine.Celebrating Da Sha bar has only sterilization debridement medicine and nonnutritive material, and result of use is all undesirable.
The object of the present invention is to provide a kind of compound method and making apparatus simple, adverse chemical reaction does not take place in compatibility, treats multiple surgical wound, trace skin ulcer, burn and scald and injures scalpel edge, the external used medicine of wide application.
Wound ointment of the present invention contains hibitane and cod-liver oil, and the part by weight of hibitane and cod-liver oil can be: the cod-liver oil of the hibitane of 0.1%-5% (weight) and 99.9-95% (weight).Cod-liver oil comprises the similar products based on cod-liver oil.Cod-liver oil series products wherein can be used the cod-liver oil raw material, or based on the various cod-liver oil finished products of cod-liver oil, as selecting for use the cod-liver oil drop (to contain V
ABe foundation), V
DDrop is (to contain V
AAnd V
D2Be according to) and vitamin A, vitamin D2, D3 mixing drop.The used various component raw material of the present invention are all the qualified products of Chinese Pharmacopoeia record, during preparation each composition mixing in the component is got final product, the ointment for preparing after the sterilization can directly be coated with usefulness, also can be applied to husky bar through autoclaving, perhaps is applied to husky bar behind the autoclaving again through concora crush sterilization back use.
The existing antimicrbial power of the present invention is strong, and the medicine of has a broad antifungal spectrum gives the wound convergence again, promotes the medicine of wound growth healing.Prescription is simple, the adverse chemical reaction of having avoided the mutually blended drug drug interaction of multiple medicine to be caused, and as the cod-liver oil series products of nutrition double as substrate again, antibiotic is favorable solubility therein, has also avoided adding in addition the interaction between substrate and medicine.Record by experiment two kinds of components before mixing content and the content deviation rate behind the mixed high-voltage fire bacterium all less than 2%, the method for testing of component content is so that " Chinese pharmacopoeia (90 years versions) is a foundation.Cure rate to the treatment symptom is adding up after the multiple class patient's administration of outpatient service, and under the situation that was administered once or changed dressings once in two days, average administration is no more than five times, recovery from illness in general three times, and cure rate 100%, none example has any adverse consequences person.Particularly diabetics uses general medicine, and the wound mouth is difficult for healing, uses medicine of the present invention, guarantees the easy healing the same with normal person's wound mouth, and curative effect is showing.
Embodiment 1,
Hibitane 0.1% (W), cod-liver oil 99.9% (W) mix homogeneously is applied on the husky bar and uses behind the autoclaving, is used to scald the back administration, changes one time medicine in per two days.Treat 12 examples altogether, the medication number of times is 10 times, cure rate 100%.
Embodiment 2,
Hibitane 2% (W), cod-liver oil 98% (W), mix homogeneously is applied to husky bar behind the autoclaving, through concora crush sterilization back use, be used for administration and post-operative wound administration after the drain, changes one time medicine in per two days.Administration time is six days, and the former treats 36 examples, and the latter treats 5 examples, and cure rate is 100%
Embodiment 3,
Hibitane 5% (W), cod-liver oil 95% (W) mix homogeneously is applied to that autoclaving uses behind the husky bar, and medicine was changed one time in be used to make skin graft back administration and the administration of open fracture wound in per five days.The former treats 4 examples, and the latter treats 3 just, changes the just basic healing of wound behind twice medicine, and cure rate is 100%.
Embodiment 4,
Hibitane 4% (W), vitamin A drop 96% (W), mix homogeneously is applied to husky bar behind the autoclaving, through concora crush sterilization back use, be used for administration after the wound, treats 64 examples altogether, and Yu that fullys recover from an illness leads 100%
Embodiment 5,
Hibitane 5% (W), vitamin AD drop 95% (W) mix homogeneously, autoclaving uses after being applied to husky bar, and the patient is for suffering from diabetes (late period) and causing uremia, and the both legs edema is broken, yellow fluid oozes out, the diabetes patient is difficult for healing after broken wound is arranged, easy ulcer, but after giving this medicine, through 5 times change dressings (changing once in general per 2 days), the recovery from illness of both legs breach there is no to be infected or other reaction.Treat 5 examples, more rate 100%
Claims (3)
1, a kind of Wound ointment is characterized in that: contain hibitane and cod-liver oil, the part by weight of hibitane and cod-liver oil is the hibitane of 0.1%-5% and the cod-liver oil of 99.9-95%.
2, as the said Wound ointment of claim 1, it is characterized in that: the part by weight of hibitane and cod-liver oil is the hibitane of 2%-4% and the cod-liver oil of 98-96%.
3, as claim 1 or 2 said Wound ointments, it is characterized in that: cod-liver oil is cod-liver oil drop or vitamin A drop or vitamin D drop or vitamin A, vitamin D2, D3 mixing drop.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97103257 CN1197643A (en) | 1997-04-30 | 1997-04-30 | Wound ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97103257 CN1197643A (en) | 1997-04-30 | 1997-04-30 | Wound ointment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1197643A true CN1197643A (en) | 1998-11-04 |
Family
ID=5166610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 97103257 Pending CN1197643A (en) | 1997-04-30 | 1997-04-30 | Wound ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1197643A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091696A3 (en) * | 2000-05-26 | 2002-06-06 | Centre Nat Rech Scient | Use of biguanide derivatives for making a medicine having a wound healing effect |
| WO2012152910A1 (en) * | 2011-05-12 | 2012-11-15 | Helmut Vockner | Novel pharmaceutical formulation |
-
1997
- 1997-04-30 CN CN 97103257 patent/CN1197643A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001091696A3 (en) * | 2000-05-26 | 2002-06-06 | Centre Nat Rech Scient | Use of biguanide derivatives for making a medicine having a wound healing effect |
| JP2003534359A (en) * | 2000-05-26 | 2003-11-18 | サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス） | Use of a biguanide derivative for producing a medicament having a scar-forming action |
| AU2001264011B2 (en) * | 2000-05-26 | 2005-09-15 | Centre National Da La Recherche Scientifique (Cnrs) | Use of biguanide derivatives for making a medicine having a wound healing effect |
| US7199159B2 (en) | 2000-05-26 | 2007-04-03 | Centre National De La Recherche Scientifique (C.N.R.S.) | Use of biguanide derivatives for making a medicine having a wound healing effect |
| WO2012152910A1 (en) * | 2011-05-12 | 2012-11-15 | Helmut Vockner | Novel pharmaceutical formulation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2391539A1 (en) | Use of poly(diallylamine) polymers | |
| CN101491586A (en) | Ointment for combating and treating skin diseases and method for preparing said ointment | |
| CN1197643A (en) | Wound ointment | |
| KR20130070307A (en) | Locally applied composition of sustained-release for treating periodontal diseases | |
| CN103495174A (en) | Multi-effect external preparation used for treating superficial skin injury and application thereof | |
| Hersle | Trimethoprim-Sulphamethoxazole in Acne vulgaris A Double-Blind Study | |
| CN105963688A (en) | Powder for curing intestinal diseases of piglet and enhancing immunity and preparation method thereof | |
| CN1261117C (en) | Medicine for treating bum, empyrosis and bedsore | |
| RU2381810C1 (en) | Wound healing gel balm | |
| CN106955291B (en) | A kind of antibacterial anti-inflammatory medicament and preparation method thereof | |
| US10232004B2 (en) | Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers | |
| CN112741900A (en) | Compound lysozyme oral spray and preparation method thereof | |
| CN112791093A (en) | Transdermal drug delivery composition for treating acne and preparation method thereof | |
| CN1182852C (en) | Medicine for curing dermatosis | |
| CN100379464C (en) | Soluble hemostatic gauze for diminishing inflammation, killing bacteria and calming pain, and its making method | |
| RU2818074C1 (en) | Hyaluronic gel for trophic ulcer healing with dimexid and msm | |
| DE2221281C3 (en) | Pharmaceutical preparations with anti-inflammatory and analgesic effects | |
| RU2095065C1 (en) | Agent for treatment of trophic ulcer and burn in leprosy patients | |
| CN101375837B (en) | Medicament composition for treating dermatopathy as well as preparation method and use thereof | |
| CN1233350C (en) | Medication formulation for burn and scald | |
| CN1672688A (en) | Medical composite chitinamine gel | |
| CN1249931A (en) | Topical pharmaceutical composition for healing wounds | |
| JPH0454126A (en) | Treating liquid and sanitary product containing the same treating liquid | |
| CN1712009A (en) | Externally-applied medicinal liquid for treating acne, rosacea and folliculitis | |
| RU2122418C1 (en) | Agent for treatment of patients with chronic hepatitis of an infectious etiology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |